Pressure-stable wound treatment product which can be cut to size for necrotic ulcers

Abstract

The invention relates to a wound treatment product which can be cut to size and which comprises a wound contact layer, a first liquid-permeable layer with a nonwoven material, and a second liquid-permeable layer with a nonwoven material. Between the first and second layer is a swelling layer, and the swelling layer contains an aqueous salt solution and superabsorbent fibers, said superabsorbent fibers being provided in a textile composite comprising at least one type of support fiber. The wound treatment product makes do without seams and is characterized by its excellent pressure stability.

Description

[0001] Pressure-resistant, cuttable wound care product for necrotic ulcers

[0002] Technical field of the invention

[0003] The invention relates to a textile, multi-layer wound care product suitable for the treatment of various wounds, in particular ulcers, and especially ulcers on the sole of the foot. Due to its special structure, the wound care product is capable of performing physical-autolytic debridement, thereby gently removing necrotic tissue from the wound and thus initiating wound closure.

[0004] Background of the invention

[0005] Wound dressings for moist wound care are generally known from the state of the art.

[0006] One variant is described in WO 2011 / 141454 A1. It is a wound pad-like or compress-like wound dressing that can be applied to a wound or used to pack deep wounds. This product comprises an absorbent / irrigating body with a circumferential welded seam and is coated with a saline aqueous solution by the manufacturer, causing the superabsorbent material it contains to swell and transform into a gel-like state. This gives the absorbent / irrigating body a dual function for wounds with heavy exudation: Wound secretions, including the components they contain, such as germs, are actively absorbed and retained by the absorbent / irrigating body. In exchange, the absorbent / irrigating body releases the saline aqueous solution into the wound, thus creating or supporting a moist wound environment.This supports wound cleansing and positive wound conditioning, thus positively influencing healing. This is referred to as interactive wet therapy, which is particularly preferred for poorly healing wounds, clinically manifestly infected wounds, or chronic wounds of various etiologies, such as diabetic gangrene, decubitus ulcers, or leg ulcers. However, wound dressings of this type have the disadvantage that they are not designed to be adjusted to the size of the wound (after production), e.g., cut to size. The reason for this is that when cutting, the outer barrier, including the welded seam, is severed and the gel then oozes out. Cutting while dry and then adding liquid later is also not possible, because after cutting, the superabsorbent particles fall out from the interior and, in the worst case, remain in the wound.Even without cutting the product, the welded seam can tear under extreme pressure, causing the gel or superabsorbent polymer (SAP) particles to leak out. Therefore, such a state-of-the-art product is not suitable for the treatment of llcera on the sole of the foot, which often occurs in diabetics, or can only be used if the patient avoids it, for example, by lying down or elevating the affected leg. Otherwise, the wound dressing risks bursting as soon as the patient shifts their weight onto the foot being treated. Treatment while lying down or using crutches is stressful for the patient. Prolonged lying down increases the risk of thrombosis, and crutches are particularly stressful for older patients.

[0007] The information presented with reference to WO 2011 / 141454 A1 applies almost identically to the wound dressing disclosed in WO 2016 / 156619 A1. This is also intended for moist wound care and is provided in the form of a sheet material consisting of several layers that are only connected at the edges by a welded seam. Otherwise, the layers can shift against each other, for example, during body movements, creating a flexible arrangement. This wound dressing cannot be cut to size and is not suitable for use on the sole of the foot.

[0008] While the above-mentioned products can be used to treat ulcers, such as those found on leg ulcers, a problem often arises: Since the products cannot be tailored to the size of the wound, they inevitably extend beyond the wound. Because they are applied in a moist form, the healthy skin surrounding the wound will swell over time. This undesirable effect is known as maceration and, in the worst case, can lead to wound enlargement.

[0009] Consequently, there is a need for a wound dressing suitable for the treatment of various wounds, especially ulcers, including those on the sole of the foot. It can be tailored to the size of the wound, removes necrosis, and creates a moist wound environment, thus promoting wound closure without restricting the patient's mobility during treatment. Furthermore, maceration of the wound edges should be avoided.

[0010] Summary of the invention

[0011] The above object is achieved by providing a wound care product comprising the following components: a) a first liquid-permeable layer comprising a nonwoven fabric, b) a second liquid-permeable layer comprising a nonwoven fabric, c) a swelling layer in the form of a nonwoven fabric with superabsorbent, polymer-containing fibers located between the first layer and the second layer, wherein the superabsorbent fibers are present in a felt with at least one other fiber type, d) an aqueous salt solution which is embedded in the swelling layer, has a pH < 7.0 in the embedded state and can be released onto a wound during wound treatment, wherein the first layer, the swelling layer and the second layer have an identical cut and lie against one another over their entire surface without any overhang, and wherein the wound care product is designed to be seamless.

[0012] Alternatively, the wound care product may consist of the above-mentioned components.

[0013] Due to the described design, the wound dressing according to the invention can be tailored to the size of the wound and, if application to the sole of the foot is planned, the patient remains mobile during treatment. Furthermore, any possible protrusion of the wound dressing beyond the sole of the foot is prevented, so that, for example, wearing shoes is still possible. When body weight is shifted onto the wound dressing, the wound is rinsed more intensively via the saline solution and when the load is subsequently removed (weight on the other leg), most of the solution is reabsorbed by the wound dressing. This results in repetitive physical autolytic debridement, which can remove cellular debris, pus and, above all, necrotic deposits. At the same time - in the event of a wound infection - pathogens are flushed from the wound and absorbed by the wound dressing, where they are retained.Together with the moist wound environment, optimal conditions are created to stimulate healing, especially of chronic wounds, and to improve the quality of life of the affected patients.

[0014] Detailed description of the invention

[0015] The term "cuttable" means that a product or material can be specifically reduced to a size intended by the user before use using a commercially available mechanical tool such as scissors, without the product or material losing its functionality and without undesirable (partial or complete) degradation of the product or material. The term "medically acceptable material" as used herein is a non-toxic, lint-free, and stable substance that does not decompose into polar or non-polar substances under normal conditions and cannot be significantly degraded by the secretions of animal or bacterial cells.

[0016] The term “atraumatic” means that a wound care product does not bond firmly to the wound, i.e. it does not dry out or grow into the wound, and that the product can be removed painlessly without disrupting the healing process.

[0017] The term “configured for application to a wound” means that the wound care product is intended to be applied to a wound for a therapeutic purpose in the sense of wound treatment.

[0018] "Ringer's solution" is an aqueous solution containing sodium chloride, potassium chloride, and calcium chloride (specifically 8.6 g NaCl, 0.3 g KCl, and 0.33 g CaCl per liter of water), which is essentially isotonic (osmolarity of approximately 308 mOsm / L). Ringer's solution is usually sterilized before use.

[0019] "Proximal," in the context of the present invention, means that a material or substance occupies a position within a wound care product such that it is positioned toward the wound during wound care application. This is the case, for example, with a wound contact layer.

[0020] “Distal” in the context of the present invention means that a material or substance occupies a position within a wound care product such that it is arranged away from the wound within this product during use in wound care, as is the case, for example, with a backing (final support layer).

[0021] "SAF" is an abbreviation for superabsorbent fibers. These fibers are capable of absorbing many times their own weight in polar liquids and can be combined with other fibers to form a stable fiber composite.

[0022] "Additive fiber" refers to a fiber that is different from superabsorbent fibers (SAF) and is therefore not a SAF itself. "Moisture Vapor Transmission Rate" or "MVTR" refers to a measurement that expresses the permeability of water vapor through a specific material in g / m 2 / 24h. The MVTR can be determined using the standard DIN EN 13726-2 (June 2002).

[0023] The wound care product according to the invention consists of at least three layers: the first layer, the swelling layer, and the second layer. All three of these layers are cut identically, so they fit together seamlessly without any overlap. However, minor production-related deviations (tolerances) are possible without compromising function. One or two layers can extend up to 5 mm beyond another layer or layers.

[0024] The pressure resistance is achieved through the product's construction, with the composition of the swelling layer, comprising a felt made of SAF and additional fibers, and the resulting elimination of a welded seam being crucial. Seamless means, in particular, that the product has no welded seam. In this way, the required pressure resistance values ​​can be achieved. Accordingly, the wound care product reacts to mechanical pressure only through elastic and thus reversible deformation. Thus, it can preferably be provided that the wound care product has a pressure resistance of at least 8 kg / 100 cm 2 , preferably 20 kg / 100 cm 2 , even better at least 50 kg / 100 cm 2 and preferably 120 kg / 100 cm 2The pressure resistance value is to be understood in relation to a force that is distributed over the entire (distal or proximal) surface of the wound care product (full-surface pressure resistance).

[0025] Pressure resistance can be tested using the following procedure:

[0026] 1) Provide a wound care product treated with aqueous saline solution that has been sterilized within the last 14 days.

[0027] 2) Place the (unpacked) product in a standard, transparent zip bag

[0028] 3) Build-up of the weight force to be tested within one second

[0029] 4) Hold the weight force for one second

[0030] 5) Reduction of weight force within two seconds

[0031] 6) Repeat steps 3 to 5 so that the weight force is applied a total of ten times

[0032] 7) Removing the product from the bag

[0033] 8) Visual inspection of both the product and the inside of the bag for any separated fibers or leaked gel. If no separated fibers or leaked gel are visible on the product itself or inside the bag, the test is considered passed for the corresponding weight force.

[0034] Preferably, the wound care product is designed in such a way that, due to its elastic properties and compressive strength, it can be turned or folded by 90°, even better by 180° along an actual or (in the case of an asymmetrical structure) imaginary center line, without any plastic deformation taking place.

[0035] In addition to the nonwoven fabric mentioned above, the first and second layers may also comprise other components, such as other fiber arrangements, as long as they do not disintegrate after cutting. Preferably, the first and second layers consist entirely of nonwoven fabric, as nonwoven fabrics are particularly resistant to fraying, even after cutting.

[0036] The swelling layer contains superabsorbent fibers (SAF), in particular superabsorbent fibers containing a superabsorbent polymer. The superabsorbent polymer preferably comprises an acrylate-containing polymer or an acrylate copolymer. The SAF can have a fiber diameter of, for example, 50 to 500 μm. A fiber diameter of 100 to 200 μm is preferred, as this diameter allows an ideal water-to-fiber ratio to develop. This allows a larger amount, for example 15 ml, of an aqueous saline solution to be released from the swelling layer into the wound, but can also be reabsorbed. This mechanism is based on chemical-physical processes such as diffusion, in which clean saline solution migrates towards the wound and rinsed-out wound exudate migrates towards the swelling layer.Second, the saline solution is partially extruded under mechanical pressure and reabsorbed by the swelling layer when the pressure is released. Options for providing and adapting SAF are discussed in more detail elsewhere.

[0037] The invention comprises a cuttable wound care product, which is understood to mean cutting in which all layers of the product are severed simultaneously. Cutting typically results in a section being separated from the entire product, thus reducing the product's surface area. However, it is also possible to simply cut the product in order to bend or fold it along the cut edge. This can be advantageous in individual cases when treating wounds on fingers or toes, as the product can be adapted particularly well to the body's contours.If the wound care product is used as a tamponade, it can also be shortened by cutting to adapt to the depth of the cavity to be treated, which represents a major advantage over the tamponade products used to date in the state of the art: the products commonly used to date are either impossible to cut, or if they can be cut, there is a risk of organic tissue growing into the product structure. In practice, attempts are often made to counteract this latter problem by soaking the required amount of a standard dressing material (such as gauze) with hydrophobic ointment and then inserting it into the cavity. Given that dressing changes are often necessary daily for cavities, the workload associated with this approach is enormous for medical staff.

[0038] The wound care product is preferably flat, i.e., has a flat distal upper surface and a flat proximal lower surface, making it ideal for wound coverage and sitting flush with the wound edges. Flat means that the respective layer has no significant elevations or depressions. Both the first and second layers can function as the underside or wound contact layer, respectively. This allows the product to be easily draped over or within a wound. The flat underside supports the atraumatic properties and reduces wound irritation.

[0039] The wound care product is also preferably round or elliptical (when viewed from above). Compared to rectangular shapes, this has the advantage that, even in its uncut state, the product resembles the shape of most chronic wounds, which (unlike, for example, cuts) usually have a circular appearance. Furthermore, it has been shown that round or elliptical shapes can be better and more permanently fixed to the sole of the foot and are less uncomfortable for the wearer than other shapes, such as rectangular shapes with rounded corners, which are often used for abrasions. Furthermore, rectangular shapes have the disadvantage that, under continuous mechanical stress—such as when walking—they quickly begin to detach from the skin around the corners. The corners tend to curl up, which leads to an unwanted elevation and can cause pressure pain in the sole of the foot.

[0040] In the case of deep tissue defects – so-called cavities – the wound care product according to the invention can be tamponed into the wound. In addition to the already mentioned wound care benefits, this also has the effect of preventing the cavity from closing prematurely at the level of the epidermis, but rather allowing tissue regrowth to occur from the center (from the floor of the wound bed) to the periphery (toward the skin surface). Otherwise, premature wound closure could lead to an abscess and significantly complicate further treatment.

[0041] The wound care product according to the invention contains a swelling layer in the form of a nonwoven fabric with superabsorbent, polymer-containing fibers. The superabsorbent fibers are combined with at least one other fiber type (additional fiber) in a felt fiber composite. The purpose of these additional fibers is to provide the swelling layer with sufficient tear and tensile strength as well as dimensional stability in a wet state and to avoid an (external) seam. Since the SAF with the additional fiber are in the form of felt, they form a stable fiber composite even after cutting. By eliminating the need for a seam, pressure resistance is significantly increased.

[0042] With regard to the swelling layer, the additional fiber ("other fiber") can be a fiber type of synthetic, natural, or semi-synthetic origin, with SAF explicitly excluded. Examples of suitable fibers of synthetic origin are polyolefin-based fibers such as polyester and polyamide. Within the group of polyesters, polyethylene terephthalate is particularly suitable. Examples of suitable fibers of natural origin include cotton and flax. An example of a fiber of semi-synthetic origin is lyocell. Natural and semi-synthetic fibers together form the group of cellulosic fibers, provided they contain cellulose components.

[0043] The additional fiber is present together with the SAF in a felt, preferably a needle felt. This means that the two fiber types are felted together. The felt can be produced as a wet felt or as a dry felt. Production as a dry felt is preferred, as this prevents redrying of the SAF. The dry felt can be provided as a needle felt, adhesive felt, or thermally bonded melt felt. In a needle felt, the additional fibers and the SAF are mechanically needled together to form a felt. In an adhesive felt, the two fiber types are bonded together by adding an adhesive (mainly through chemical interaction). The adhesive used should not be water-soluble after curing, as otherwise it could deteriorate due to the effect of the aqueous salt solution.In a melt-felt, the additional fiber is selected from the melt-felt range and bonded to the SAF (which possess inherent melt-felt properties) using thermal energy. Preferably, the fibers of the swelling layer are in the form of needle felt. A swelling layer in the form of needle felt offers the advantage of being compatible with all sterilization methods, as it exhibits excellent resistance to heat, pressure, steam, radiation, and ethylene oxide. Furthermore, the needle felt form allows for considerable flexibility in the selection of fibers and exhibits a very long shelf life, even after extended storage.

[0044] The swelling layer constructed in this way can be easily cut without the SAF and the additional fiber separating from each other and without superabsorbent particles, such as those frequently used in absorbent wound dressings, falling out of the swelling layer in the cut area. Furthermore, permanent attachment to the other layers of the wound care product is enabled. For example, it is possible to bond the swelling layer on its distal and proximal sides to the nonwoven fabric of the first and second layers, even if these contain different materials than the swelling layer. One possible way to obtain such a laminate is described in Example 1.

[0045] The wound care product according to the invention is excellently suited for moist wound treatment. "Suitable for moist wound treatment" or "for moist wound treatment" means that the product can be used without further preparation or modification, so that moist wound treatment begins immediately upon application. This allows the wound care product to be stored in a moist state between production and use without compromising its structural integrity.

[0046] The saline solution contained in the swelling layer irrigates the wound, dissolving deposits such as fibrin, supporting the autocatalytic degradation of necrotic tissue, and removing microorganisms. Excess matrix metalloproteinases are flushed from the wound, and stagnant healing processes are restarted. The moist environment also generally accelerates wound closure.

[0047] If the product is applied to the sole of the foot, the movement stimulates venous drainage, which is particularly important for chronic wounds caused by venous congestion (e.g., leg ulcers, also known as "open leg"). Since the shape of the product can be tailored to the wound by cutting it to size, it prevents the wound from overhanging and thus preventing maceration of the surrounding skin, despite moist wound care. Furthermore, this makes the product much more comfortable to wear under a compression bandage or compression stocking, such as those used for pressure ulcers to relieve pathological venous congestion.

[0048] The wound care product according to the present invention is excellently suited for the treatment, particularly for moist wound treatment, of difficult-to-heal or non-healing and chronic wounds. These include, in particular, the following wound types: diabetic foot lesions, venous leg ulcers, arterial leg ulcers, mixed leg ulcers, and decubitus ulcers. These wounds are often characterized by the presence of deposits (e.g., fibrin deposits) and necrosis. Furthermore, the inhibited healing process appears to be associated with an imbalance of the necessary messenger substances, enzymes (e.g., matrix metalloproteases), and molecular inhibitors in the wound. Irrigating the wound as part of moist wound treatment eliminates the previously prevailing chemical imbalance, allowing a favorable environment for wound healing to develop. The previously inhibited healing process is thus restarted.As already mentioned, the wound care product according to the invention can in most cases be combined with compression therapy in order to eliminate venous congestion as the underlying ulcer-causing problem.

[0049] Particularly suitable means for securing the wound care product according to the invention to the wound site or in a deep wound (cavity) are secondary dressings such as adhesive films, gauze, bandages, and roll plasters. Adhesive films are preferred among these means because, like the wound care product itself, they can be cut to size without losing function or fraying. Furthermore, adhesive films reduce evaporation and, even when applied to the sole of the foot, do not impede the patient's walking. Furthermore, adhesive films can be made waterproof, thus protecting the wound care product from unwanted external influences (e.g., when showering).

[0050] The nonwoven fabric of the first layer and / or the second layer can be thermally bonded and thus contain thermally bonded fibers. This increases the bond strength and simultaneously allows for the creation of lighter nonwovens, resulting in material savings. At the same time, water permeability is maintained. The thermally bonded nonwoven fabric can contain thermoplastic fibers. Examples include polypropylene (PP), polyvinyl chloride (PVC), polyethylene (PE), polyester (PET), polyacrylic (PC), polyacrylonitrile (PAN), polyamide (PA), polyurethane (PU), viscose (CV), and blends of two or more of these fiber types. Furthermore, additional thermoplastic components can be included. An example of a thermoplastic additional component is PET.

[0051] To produce a suitable thermally bonded nonwoven fabric, the resulting loose

[0052] The fibers laid in the nonwoven fabric are heated to their melting point, causing them to bond. Calender bonding (also called thermobonding) or hot air bonding (also called thermofusion) can be used, although calender bonding has proven particularly effective in the case of PP fibers.

[0053] When using fibers that are not suitable for thermal bonding in their pure form, binding fibers can be added to enable thermal bonding. Thus, the thermally bonded nonwoven can contain other fiber types such as cotton or viscose in addition to thermoplastic fibers and thermoplastic additives. These fibers are preferably natural or semi-synthetic fibers such as viscose.

[0054] Heat transfer for thermal bonding can be achieved by conduction, convection, or radiation. The calendering and hot-air processes are particularly suitable. This type of bonding enables the transformation of a loose fiber web into a strong, durable nonwoven fabric. This significantly reduces the risk of fibers becoming detached and entering the wound.

[0055] The SAF in the swelling layer may comprise or consist of a polymer containing acrylate. This may be a polyacrylamide or a derivative of a polyacrylamide, or an acrylamide copolymer. According to a preferred embodiment of the invention, the SAF in the swelling layer of the wound care product contains a polymer that is crosslinkable. An example of crosslinkable polymers from which SAF can be derived or which can form a component of SAF are acrylate-containing polymers.

[0056] The SAF in the swelling layer of the wound care product can preferably contain a cross-linked polymer. The cross-linking is preferably based on the formation of ester bonds. The cross-linked polymer can be cross-linked or cross-linkable through these ester bonds. The degree of cross-linking can be used to adjust the flexibility or resistance of the SAF (flexural moment of resistance) in the presence of the aqueous saline solution. The higher the degree of cross-linking, the tougher the gel-like consistency of the SAF, which can exist as hydrogels in the presence of water or other aqueous fluids such as wound exudate. At the same time, the resilience of the swelling layer and thus of the wound care product as a whole increases with the degree of cross-linking.

[0057] The crosslinking bonds can be acrylic ester bonds. Crosslinking can occur via radical or cationic polymerization mechanisms or other esterification or transesterification mechanisms, such as the Michael addition. Radical polymerization is preferred. Polyacrylamides can be crosslinked by introducing them into an acidic environment. Depending on the desired reaction rate, the pH can be less than 6.0, less than 5.0, or less than 4.0. For example, the pH can range from 3.0 to 6.0, or from 1.0 to 5.0, or from 0.0 to 4.0.

[0058] In this context, the SAF can contain a polymer that is 5 to 50% crosslinked, preferably 10 to 40%. For acrylic-containing polymers, the degree of crosslinking can be determined based on the amount of acrylic groups crosslinked via ester bonds within the polymer. Thus, with a degree of crosslinking of 50%, half of the acrylic groups would be crosslinked.

[0059] Furthermore, the SAF may contain a copolymer, which may be an acrylic copolymer.

[0060] One possible example is poly(acrylic acid-co-acrylamide) / polyvinyl alcohol. This can be spun directly into SAF.

[0061] The cross-linking of SAF does not preclude its needling with at least one other fiber type (an additional fiber that is not an SAF) to form a needle felt. Cross-linking can take place either before or after needling, although it is recommended that it be carried out before needling, as this allows the degree of cross-linking to be adjusted more precisely. Thermal bonding can follow needling, with these three processes (cross-linking, needling, and thermal bonding) complementing each other synergistically and resulting in an effervescing layer that exhibits excellent moisture retention, moisture release, and excellent mechanical strength, even after cutting by the end user or caregivers. The ratio of SAF to additional fiber in the effervescing layer can, for example, be as follows: 20 wt% to 80 wt% SAF and 80 wt% to 20 wt% additional fibers.The proportion of SAF in the swelling layer is preferably 20 wt.% to 60 wt.%, particularly preferably 20 wt.% to 40 wt.%, with the remaining proportion being provided by the additional fibers. One possible embodiment contains 25 wt.% SAF and 75 wt.% polyolefin-based fibers in the swelling layer.

[0062] According to the invention, the swelling layer, the first layer, and the second layer are bonded to one another over their entire surface (i.e., over the entire area of ​​the respective top and bottom sides). The surfaces can be bonded to one another adhesively, whereby the adhesive connection of the surfaces can be direct (directly adjacent) or indirect - e.g., by inserting further intermediate layers such as a perforated, double-sided adhesive film or a porous melt film (thermoplastic). The layers can be joined or bonded together adhesively, for example, by an adhesive or an adhesive bond. The adhesive bond or adhesive layer can be present in the finished product as a cohesive layer, i.e., within it, the particles of the adhesive (atoms, molecules, etc.) attract one another. Preferably, it is a hot-melt adhesive or a hot-melt adhesive bond.Examples of possible hot melt adhesives are copolymers and polyolefin-based hot melt adhesives such as polyester or polyester derivatives such as co-polyester. Such hot melt adhesives are ideal for permanently joining nonwoven layers, particularly those containing synthetic fibers. They are also generally technically compatible with subsequent heat sterilization. The melting point can also be below the subsequent sterilization temperature, as the product is already in outer packaging during sterilization, which gives the product additional stability. The melting point of the hot melt adhesive or hot melt adhesive compound can, for example, be between 45 °C and 120 °C, preferably between 45 °C and 70 °C. If necessary - e.g. through the use of co-polyester - maximum melting points of up to 140 °C and sometimes even higher can be achieved.It is recommended to sterilize the wound care product in a moist state (i.e. with the aqueous saline solution it contains), since in this way low sterilization temperatures (e.g. 120 °C) may already be sufficient, provided that a sufficient exposure time is ensured.

[0063] The above-mentioned hot melt adhesives can be added to the melting process in various starting materials. This makes it possible to provide the hot melt adhesive in the form of particles, as a mesh, or as a film. Providing the adhesive in the form of particles or a mesh is preferred because it does not restrict the mobility of the resulting product. Particles also offer the advantage of flowability. Films and meshes are particularly suitable when different hot melt adhesives are to be combined. Hot melt adhesive combinations can lead to particularly strong adhesive bonds, with one of the adhesives used fixing the respective layers during the manufacturing process, and the other adhesive (with a higher melting point) reacting during the sterilization process and further strengthening the initial bond without the need for additional thermal energy during the process.

[0064] The layers of the wound care product—particularly the first layer, the swelling layer, and the second layer—can be presented as a laminate. These can be bonded together using either thermal energy and / or adhesives. Using non-heated adhesives also creates a laminate, which in this case is a cold laminate. It is recommended to apply the aforementioned hot melt adhesive between the layers to make the resulting laminate more durable. The required temperatures depend on the materials to be treated and can, for example, range from 45–160°C. Typically, an exposure time of 2 seconds to 10 minutes is sufficient. The optimal exposure time varies depending on the selected temperature, but in most cases is in the range of 2 to 30 seconds.

[0065] The layers of the wound care product cohesively joined in this way have the advantage of forming a flat bond that continues to hold the layers together even after the product has been trimmed. This flat bond is preferably a full-surface adhesive bond, particularly preferably a full-surface adhesive bond, and ideally a full-surface hot-melt bond. Conversely, methods that only join the individual layers along their edges (e.g., conventional welding) do not result in a product that can be cut to size.

[0066] Other ways to connect the layers together include anchoring fibers from one layer into an adjacent layer. In this way, two layers can be connected, for example, by weaving or felting.

[0067] The wound care product can be cut into two or more segments. All segments obtained in this way can be used in wound care. The segments obtained by cutting are capable of releasing the aqueous saline solution stored in the swelling layer into the wound, thereby irrigating and cleansing it.

[0068] A further aspect of the invention relates to a cuttable, flat wound care product in which the first layer, the swelling layer, and the second layer are joined together in a flat manner via a fusion bond, and wherein the fusion bond contains or consists of a fused polyolefin or fused copolymer. Such a laminate can advantageously be cut without fraying at the cut edges.

[0069] A particular advantage of the cuttable, flat wound care product according to the invention is that the rinsing effect emanating from the wound care product is reinforced or intensified upon repeated reversible (non-plastic) deformation or repeated pressure compression of the wound care product. This can be achieved in practice, for example, by applying the wound care product to the sole of the foot and then repeatedly applying and releasing pressure when walking by the patient or end user. In this way, the wound care product is compressed by body weight upon walking, and the portion of the aqueous saline solution not firmly bound to the SAF is partially forced out of the wound care product. As soon as the patient lifts their foot and the wound care product expands again, a portion of the released saline solution (together with dissolved substances, pathogens, etc.) is reabsorbed.This process takes place repetitively while walking, which allows for particularly intensive irrigation of the wound.

[0070] Another option, for example, when treating an open leg, is to apply the wound care product and then wrap it with a compression bandage. The compression bandage acts as a counterforce to the so-called venous-muscle pump. The wound care product is compressed between the body surface and the compression bandage during muscle contraction. During subsequent muscle relaxation, the wound care product can expand again. Muscle tension occurs involuntarily when walking. If a patient is bedridden, suitable exercises can alternatively be performed while lying down – for example, under the supervision of a physiotherapist. A beneficial, enhanced irrigation effect also occurs in the cases mentioned here.

[0071] For the purposes of this aspect (enhanced irrigation effect), the term repeated reversible deformation or repeated pressure compression can mean that the wound care product is capable of enhanced irrigation of the wound if it is deformed or compressed at least three times and each time essentially returns to its original shape without additional assistance. Enhanced irrigation is understood to mean irrigation in which a larger volume of aqueous saline solution is delivered (e.g., to a wound or a measuring device) compared to purely passive mass transfer (without deformation or compression) along the concentration gradient. In this case, the wound care product can, in its initial state, be saturated with the aqueous saline solution to, for example, 80% of its maximum absorption capacity.

[0072] In the context of the invention, the wound care product is capable of generating a muscularly driven pumping effect during wound treatment to rinse the wound to be treated with the aqueous saline solution contained in the swelling layer, in particular when walking when the product is fixed to the sole of the foot.

[0073] The rinsing effect, which is intensified in this way, enables extremely gentle cleaning of the wound from necrosis and fibrin deposits, which generally avoids surgical invasive cleaning using a scalpel, sharp spoon, etc., which is stressful for the patient.

[0074] Preferably, the enhanced rinsing effect simultaneously represents an enhanced suction / irrigation effect, which is accompanied by increased absorption of substances absorbed from the wound. For example, microorganisms flushed from the wound are retained in the effervescing layer and removed during the next dressing change.

[0075] Furthermore, it can be provided that after cutting the wound care product according to the invention, the structural integrity of the remaining area intended for wound care is maintained, so that, due to the felt structure of the swelling layer, no fibrous or particulate components of the cut wound care product, in particular no superabsorbent fibers, are released. Such a wound care product is thus lint-free, even after cutting immediately before use.

[0076] In the wound care product according to the invention, it can be provided that the pH of the aqueous saline solution of less than 7.0 is mediated by an acid group contained in the superabsorbent fibers, preferably by acrylic acid. This acid group can be part of the polymer contained in the SAF or from which the SAF consists. The polymer can be polyacrylic acid. The advantage is that further components for acidification can be dispensed with and a pH value in the slightly acidic range that promotes healing for the vast majority of wounds can be set. The pH of the aqueous saline solution mediated by said acid group is preferably in the range of 4.5 to 6.9. The pH value is particularly preferably in the range of 5.0 to 6.5.

[0077] Furthermore, it is preferably provided that the first layer, the swelling layer, and the second layer exhibit a substantially identical lateral increase in size upon absorption of liquid. Substantially identical lateral increase in size means that the areal expansion of these layers increases to the same extent when they absorb moisture, whereby small area differences of up to 5%, preferably up to 3%, between the adjacent layers are possible and included. The expansion can be determined according to the AATCC TM 135 standard. Regarding any possible shrinkage after liquid release, this applies analogously to the reduction in the area of ​​the layers.

[0078] The advantage of an essentially equal change in the surface area of ​​the three layers upon contact with liquid is that moisture absorption does not lead to deformation (e.g. curvature or bulging) of the wound care product and the planar shape is maintained.

[0079] In this context, the first layer, swelling layer, and second layer can also have the same or essentially the same thermal lateral expansion coefficient, which refers to the surface area. Differences of up to 5%, preferably up to 3%, between the adjacent layers are included as tolerances. An identical or essentially identical thermal lateral expansion coefficient offers an advantage during heat sterilization of the wound care product. Otherwise, undesirable deformation of the product may occur during sterilization, and sterilization must be performed using other (usually more complex or expensive) methods, such as irradiation or fumigation with ethylene oxide.

[0080] Identical or essentially identical expansion or thermal expansion can be achieved by using multiple layers of materials that exhibit the same or very similar expansion behavior. Synthetic fibers, for example, exhibit very similar expansion and shrinkage behavior both to each other and to cotton. According to the invention, the swelling layer of the wound care product comprises at least one other fiber type or at least one additional fiber in addition to SAF. This is advantageously a cellulose-containing fiber such as lyocell or a polyolefin-based fiber containing, for example, PE.

[0081] Lyocell fibers have the advantage of excellent moisture retention, exceeding the already high capacity of cotton. Thus, lyocell fibers synergistically support the SAF, providing the necessary structural strength to the swelling layer and keeping the SAF in place within the swelling layer.

[0082] Furthermore, with regard to the wound care product according to the invention, it is possible for the nonwoven fabric of the first layer and / or the second layer to contain viscose and polyester or to consist of these polymers. The polyester content in the nonwoven fabric can be, for example, 30 to 50 percent by mass. The addition of the hydrophobic polyester creates a hygroscopic gradient starting from both the first layer and the second layer, which conducts fluid through the latter two layers towards the swelling layer. At the same time, the aqueous saline solution coming from the swelling layer can pass through the first and second layers and then reach the wound without being retained in the first or second layer.

[0083] Furthermore, it is possible for the first and second layers to be made of an identical material or an identical material blend and / or to have the same basis weight. These can be the materials or material blends listed in the last paragraph. Using identical materials for both layers ensures that both layers have the same properties. This is even more true when they have the same basis weight. This avoids operating errors by the user, where the wrong or suboptimal side is placed on the wound. In addition, when tamponing a cavity, such a structure offers the advantage that all wound walls (regardless of their spatial location) are contacted and treated with identical material, resulting in a consistent treatment effect with every use.

[0084] In general, it is possible that the nonwoven fabric of the first layer and / or the second layer has a basis weight of 15 to 50 g / m 2 , for example 18 to 45 g / m 2 , has. The basis weight can be determined according to the DIN EN 12127 standard. It has been shown that layers of this type combine excellent structural strength with high fluid permeability. The layers remain resilient even after possible cutting, but do not impair the desired absorption / irrigation effect of the wound care product.

[0085] The wound care product according to the invention can have different external shapes and dimensions. For the treatment of an (external) wound, a shape that is flat on both sides (i.e. both proximal and distal) is recommended. For the treatment of ulcers on the sole of the foot, it is also advantageous to design the wound care product with a low height. Such wound care hardly disturbs the patient in their usual daily routine, if at all, since the patient can wear the product under socks and in shoes and even walk with it. Such a low height is 1.5 mm to 6 mm. Should the wound care product only have the minimum structure of a first layer, swelling layer, second layer and optional adhesive layers, the height can be an even more advantageous 1.7 mm to 3 mm, preferably 1.7 mm to 2.5 mm and particularly preferably 1.8 mm to 2.2 mm.The specified height ranges refer to the dry composite described in the present application (i.e., without aqueous saline solution) consisting of the first layer, swelling layer, and second layer, and also without optional release liners or other packaging material. The height of the product treated with the aqueous saline solution can result in an approximately 10% increase in height (depending on the applied volume). Consequently, the wound care product in the moist state would, for example, have a height of 1.7 mm to 6.6 mm, better 1.9 mm to 3.3 mm, even better 1.9 mm to 2.8 mm, and most preferably 2 mm to 2.4 mm.

[0086] Examples of other possible shapes include cushion-shaped and cylindrical. The cushion-shaped version provides a particularly good cushioning effect. This is particularly comfortable for patients, for example, in the case of wounds on the ankle. The cylindrical version is particularly advantageous for tunnel-shaped wounds and cavities, where any protruding end (protruding from the wound) can simply be trimmed off. This prevents premature superficial wound closure with underlying encapsulation and subsequent abscess formation.

[0087] In terms of shape, the wound care product can be round, rectangular, square, oval, or diamond-shaped when viewed from above. The surface area can, for example, be 50 cm 2 up to 500 cm 2, whereby larger surfaces offer the advantage of being able to be tailored to the respective wound size. The swelling layer of the wound care product preferably contains the aqueous saline solution in an amount that does not exhaust the absorption capacity of the swelling layer. This means that the swelling layer is preferably not saturated or unsaturated. In this way, the swelling layer or the wound care product can absorb further liquid such as wound exudate or blood. Thus, it is possible for the swelling layer or alternatively the entire wound care product to be saturated with the aqueous saline solution to a maximum of 50%, a maximum of 60%, a maximum of 70%, a maximum of 80%, a maximum of 90% or a maximum of 95%. It is possible to adapt the swelling layer in its composition, density and / or thickness (height extension) such that at least 30 g, better at least 35 g, even better at least 38 g and most preferably at least 40 g of Ringer's solution per 100 cm 2The swelling layer area must be absorbed within 10 minutes from a flat container with a Ringer solution filling height of 2 mm and a total Ringer solution volume of at least 50 ml.

[0088] The fluid release of the swelling layer or wound care product (in terms of the intended wound irrigation effect) can be at least 8 wt.%, better at least 10 wt.%, even better at least 13 wt.%, and most preferably at least 15 wt.% of the maximum absorption capacity of the swelling layer or wound care product. The method for determining fluid release is described in the examples.

[0089] The fluid retention capacity of the swelling layer or wound care product can be at least 60 wt.%, better at least 70 wt.%, even better at least 80 wt.%, and most preferably at least 90 wt.% of the maximum absorption capacity of the swelling layer or wound care product. The method for determining the fluid retention capacity is shown in the exemplary embodiments.

[0090] Which of these values ​​is most suitable depends on the type of wound being treated. The more heavily a wound is covered with deposits (e.g., fibrin deposits), necrotic tissue, or biofilm, the more it will benefit from intensive irrigation, so high saturation values ​​of 80% or more are recommended in such cases. In contrast, heavily exuding, non-infected wounds can be treated with variants of the product that have a lower saturation in the range of 50% to 70%.

[0091] The given saturation values ​​are explained below using an example: If the source layer can absorb a maximum of 100 ml of an aqueous salt solution (osmotic value in the isotonic range, i.e. 9 g NaCl to one liter H2O), the source layer is 50% saturated after absorbing 50 ml.

[0092] Furthermore, the specified saturation values ​​can also refer to a wound care product with the three main layers (first layer, swelling layer, second layer and optional intermediate adhesive layers) or to the entire wound care product, which can also have additional layers as required.

[0093] Furthermore, it may be determined that the wound care product is not suitable or compatible with negative pressure therapy because, for example, it does not have a port through which negative pressure can be applied to the product or a wound underneath the product.

[0094] Within the scope of the present invention, it can be provided that the wound care product contains no superabsorbent particles. Preferably, it contains no particles at all that could fall out after the product has been cut to size. Exceptions to this are adhesive particles that can be used during the manufacture of the product, as these bond with the other materials and do not impede the desired effect of being cut to size. Active ingredient particles that dissolve in the aqueous saline solution are also not excluded from the inventive concept.

[0095] The salt present in the aqueous saline solution can be NaCl. The aqueous saline solution is preferably isotonic. Such an isotonic saline solution has essentially the same osmotic pressure as human blood. Minor deviations in the pressure value of 1% in Pascal, either up or down, are tolerable and also fall under the term "isotonic solution."

[0096] In addition to NaCl, the aqueous saline solution can also contain other salts such as KCl or salt combinations such as KCl and NaCl. A preferred variant of the aqueous saline solution is the so-called Ringer's solution, which contains CaCl in addition to NaCl and KCl and is isotonic.

[0097] An isotonic solution offers the advantage that the unprotected cells in the open area of ​​the wound to be treated are not exposed to osmotic stress. Rather, the supply of minerals contained in the saline solution has a positive effect on cellular metabolism. Human cells are able to absorb minerals from the environment via membrane-bound proteins such as aquaporins. The aqueous saline solution stored in the swelling layer can pass from the swelling layer into the other layers of the wound care product. In particular, the aqueous saline solution can be present in both the first and second layers. This does not impair the functionality of the product. In fact, it is desirable for the solution to pass through the first and / or second layers, at the latest after application to or in the wound.When determining the amount of solution required to wet the swelling layer, the absorption capacity of the other layers can be taken into account.

[0098] In the following, the invention will be explained in more detail with reference to exemplary drawings, whereby the variants shown can be modified depending on the intended use with the help of the technical information contained in this document.

[0099] Figure 1 shows an embodiment of the wound care product according to the invention, which is excellently suited for use as a tamponade (ie for tamponing cavities and deep wounds), in cross section.

[0100] Figure 2 shows the product of Figure 1 in a cut-out form in top view.

[0101] Figures 1 and 2 depict a wound care product (5) according to the invention, comprising a second, liquid-permeable layer (1) made of nonwoven fabric at the top, which is attached to the swelling layer (3) by means of an adhesive layer (2). Within the swelling layer is a fiber composite containing needle-punched superabsorbent fibers and additional fibers, wherein the additional fibers are not superabsorbent fibers. The swelling layer (3) is treated with an aqueous saline solution (not depicted). Below the swelling layer (3) is the first liquid-permeable layer (4). The swelling layer (3) and first layer (4) are joined together by means of an adhesive layer (2). In the illustration in Figure 2, the wound care product (5) is cut in the middle into two halves (segments). The structural unity and functionality of each half are maintained.

[0102] Fig. 3 shows the fluid release of the wound care product according to the invention and a control wound dressing within 24 hours and 72 hours in a bar chart. The wound care product is symbolized by solid black bars, while the control product is symbolized by contoured bars. Further details can be found in the corresponding exemplary embodiment.

[0103] Fig. 4 shows the fluid retention capacity of the wound care product according to the invention using a bar chart. Further details can be found in the corresponding exemplary embodiment. Fig. 5 shows the absorption capacity of the wound care product according to the invention and a control wound dressing in a bar chart. The wound care product is symbolized by a solid black bar, the control by a contoured bar.

[0104] Examples

[0105] The invention is explained in more detail below using exemplary embodiments:

[0106] Example 1: Manufacture of a wound care product for use as a tamponade

[0107] First, a swelling layer (4) was provided by the meter. A first liquid-permeable layer (4) in the form of a PP nonwoven fabric was attached to the underside of the swelling layer (4). A second liquid-permeable layer (1), also made of a PP nonwoven fabric, was attached to the top of the swelling layer. To attach the layers together, adhesive particles in the form of biodegradable polyester were applied between the layers. The adhesive particles were then bonded together in a subsequent thermal bonding process. This was achieved by thermal treatment in a drying oven at a temperature of over 120°C, followed by roller compression. The resulting three-layer laminate had a basis weight of 260 g / m². 2at a thickness of 2.3 mm. In the next step, the laminate was wound onto a roll and fed from this roll into a converting machine, where square sections measuring 10 cm x 10 cm were cut out of the laminate.

[0108] The products were then processed using a packaging machine. In the packaging machine, the previously dry products were spread out on a liquid-tight packaging film. Aqueous saline solution was added in an amount that did not exhaust the maximum absorption capacity of the products (approximately 31 ml). Sealing followed with an upper packaging film (liquid-tight), so that the wound care products (5) were enclosed between the lower and upper films. The resulting bag, together with the products contained therein, was then steam sterilized at 120°C. The now moist wound care products (5) were then stored in a sterile manner in the bag, which also served as part of the packaging material. The resulting sterile products (5) can be used for tamponing wounds (e.g., cavities) after removal from the bag. Example 2: Cutting the wound care products

[0109] The wound care product (5) according to Example 1 was cut in half approximately in the middle (i.e., approximately 5 cm from the left and right edges, respectively) using standard scissors. The cutting process was performed effortlessly and without any particular force. The cut edges were visually assessed. No fraying or loose fibers were observed. The cut surfaces were flat, smooth, and straight.

[0110] Furthermore, the layers of the cuts continued to form a stable bond and showed no tendency to separate, disintegrate, or delaminate. Thus, each individual cut was suitable for use in wound care.

[0111] Example 3: Measurement of maximum pressure load

[0112] A moist wound care product (5) approximately two weeks old, as described in Example 1—but in a circular shape—was prepared and placed in a commercially available transparent plastic ZI P bag. The bag was sealed and placed in a calibration device from Sensomative for further testing. The wound care product (5) was circular (viewed from above) with a diameter of 4.5 cm. Loading cycles were then performed, each of which applied a weight force of 188.5 N (equivalent to approximately 19 kg) to the entire surface of the product within 1 second. The weight force was maintained for one second and then reduced to 0 N within 2 seconds. The number of loading cycles was ten. The process took place at a temperature between 22°C and 23°C.The weight force was transmitted using an inflatable envelope made of synthetic, airtight material installed in the calibration device. The envelope was pneumatically inflated during the loading cycles.

[0113] After the stress test, the product (5) was removed from the system. Both the product (5) and the bag were visually inspected. No material breakage was observed. All layers (1, 3, 4) of the product (5) were structurally intact. After removing the product (5) from the bag, no torn fibers or leaked gel were visible on the product (5), nor could any separated or leaked materials be detected inside the bag. Only a small amount of the aqueous saline solution remained in the bag. Example 4: Determination of Liquid Release

[0114] The release of fluid is crucial for the intended wound irrigation effect.

[0115] A swelling layer described in Example 1 was prepared in a circular design with a diameter of 4.5 cm. As stated in Example 1, the swelling layer contained Ringer's solution without being saturated with it. After determining the weight of the swelling layer (r ), it was placed on a hydrogel dressing ("HydroTac transparent™" from HARTMANN, cut to the approximate area of ​​the swelling layer). The swelling layer lay on the wound contact surface of the hydrogel dressing and thus had contact with the hydrogel. The hydrogel dressing simulated the plasticity and fluid absorption capacity of human tissue. Both components were then shrink-wrapped together in a vapor-impermeable film. In the next step, a cardboard box approximately the same size as the hydrogel dressing was placed on top of the welded combination of swelling layer and hydrogel dressing. An Erlenmeyer flask filled with water was placed inside the cardboard box.The carton and filled plunger together weighed 250 g, simulating the contact pressure of a secondary dressing. The weight of the wound dressing (m²) was determined after 24 and 72 hours. The fluid output of a total of 40 specimens (20 per period) was tested, and the average value was calculated.

[0116] The control was a moist wound dressing described in WO 2016 / 156619 A1 with the following structure: a wound dressing with a nonwoven-based absorbent / irrigating body containing superabsorbent particles mixed with cellulosic and thermoplastic fibers. The absorbent / irrigating body was provided with a covering forming the outer visible sides of the wound dressing. The covering consisted of a knitted textile fabric on the wound-facing side and a nonwoven fiber layer on the nonwoven side. A liquid-impermeable plastic film layer was placed between the nonwoven fiber layer and the absorbent / irrigating body. The knitted fabric, the absorbent / irrigating body, the plastic film layer, and the nonwoven fiber layer were not bonded to one another over the entire surface, but were held together merely by a welded joint along their peripheral edges. The control was also saturated with Ringer's solution. Forty test specimens were also tested, and the mean values ​​were determined.

[0117] The liquid release [%] was determined using the following formula: 100% - (m2 x 100%) / nm. The results are shown in Fig. 3.

[0118] Example 5: Determination of liquid retention capacity

[0119] Fluid retention capacity is important to prevent the wound care product from being completely squeezed out. To ensure continuous fluid exchange between the wound care product and the wound, providing a suction / irrigation effect, residual fluid should remain in the wound care product even under pressure. The pressure of 35 mmHg applied during the subsequent measurement corresponds to the force typically applied during compression therapy (often used in the context of a leg ulcer to treat venous insufficiency).

[0120] A swellable layer was prepared as described in Example 1, in a circular configuration with a diameter of 4.5 cm. As stated in Example 1, the swellable layer contained Ringer's solution without being saturated with it. First, the weight of the swellable layer (r ) was determined. The swellable layer was placed on a grid. The grid was held in the air using four identical spacers. A weight of 760 g was placed on the swellable layer. After 10 minutes, the swellable layer was weighed again.

[0121] Retention was determined using the following formula: (m2 x 100%) / nm. Twenty samples were tested, and the measured values ​​were averaged. The results are shown in Fig. 4.

[0122] Example 6: Determination of absorption performance

[0123] Absorption capacity is a measure of the absorbency of a wound care product. This absorbency allows pathogens, fibrin deposits, and excess matrix metalloproteases, for example, to be absorbed and trapped within the wound care product.

[0124] A wound care product was prepared as described in Example 1 (circular, diameter 4.5 cm). As stated in Example 1, the product contained Ringer's solution without being saturated with it. After determining the weight, the product was placed in a desiccator containing a drying agent. A 0.9% solution of NaCl in water was poured into the desiccator. The desiccator was closed and a vacuum was applied for 30 minutes. After this time, the product was removed and hung up to drain for 5 minutes. The weight of the product was then determined again. The measurement was carried out on a total of ten products, and the mean value was determined. To determine a comparison value, ten control wound dressings were also measured in the same way as described in Example 4, and the mean value was also determined here. The results are shown in Fig. 5.

Claims

Patent claims 1. Cuttable wound care product (9), comprising a) a first liquid-permeable layer (4) comprising a nonwoven fabric, b) a second liquid-permeable layer (1) comprising a nonwoven fabric, c) a layer located between the first layer (4) and the second layer (1) Swelling layer (3) in the form of a nonwoven fabric with superabsorbent, polymer-containing fibers, wherein the superabsorbent fibers are present with at least one other fiber type in a felt, d) an aqueous salt solution which is embedded in the swelling layer (3), has a pH < 7.0 in the embedded state and which can be released to a wound during wound treatment, wherein the first layer (4), the swelling layer (3) and the second layer (1) have an identical cut and lie against one another over their entire surface without any overhang, and wherein the wound care product (9) is designed to be seamless.

2. Cuttable wound care product (9) according to claim 1, wherein the wound care product (9) has a pressure resistance to a pressure of at least 8 kg / 100 cm 2 so that the wound care product (9) is only elastically deformed by the action of such pressure.

3. Cuttable wound care product (9) according to claim 1 or 2, wherein the other fiber type is selected from the group consisting of: cellulose-containing fiber, polyester-containing fiber, preferably polyethylene terephthalate and / or polyamide, and wherein the other fiber type is needled to the superabsorbent, polymer-containing fibers so that it is present in a needle felt.

4. Cuttable wound care product (9) according to one of the preceding claims, wherein the nonwoven fabric of the first layer (4) and / or the second layer (1) contains thermally bonded fibers.

5. Cuttable wound care product (9) according to claim 4, wherein the thermally bonded fibers contain or consist of one or more polymers selected from polypropylene, polyvinyl chloride, polyethylene, polyethylene terephthalate, polycarbonate, polyamide, polyurethane, polystyrene, and mixtures thereof.

6. Cuttable wound care product (9) according to one of the preceding claims, wherein the superabsorbent fibers in the swelling layer (3) contain a polymer, preferably an acrylate-containing polymer or an acrylate copolymer, which is cross-linkable, wherein the cross-linkability is preferably based on the formation of ester compounds.

7. Cuttable wound care product (9) according to one of the preceding claims, wherein the first layer (4), the swelling layer (3) and the second layer (1) are present as a laminate.

8. Cuttable wound care product (9) according to one of the preceding claims, wherein the first layer (4), the swelling layer (3) and the second layer (1) are permanently bonded to one another over their surface, wherein the layers are preferably joined together by a hot-melt adhesive, and wherein the hot-melt adhesive preferably contains or consists of a polyolefin or copolymer.

9. Cuttable wound care product (9) according to one of the preceding claims, wherein during cutting the structural integrity of the wound care product (9) is retained, so that no fibrous or particulate components of the wound care product (9), in particular no superabsorbent fibers, are released through the felt structure of the swelling layer.

10. Cuttable wound care product (9) according to one of the preceding claims, wherein the nonwoven fabric of the first layer (4) and / or the second layer (1) has a basis weight of 15 g / m 2 up to 50 g / m 2 has.

11. Cuttable wound care product (9) according to one of the preceding claims, wherein the wound care product (9) has a height of 1.7 mm to 6.6 mm.

12. Cuttable wound care product (9) according to one of the preceding claims, wherein the swelling layer is saturated to a maximum of 95% with the aqueous saline solution.

13. A cuttable wound care product (9) according to any one of the preceding claims, wherein the aqueous saline solution contains NaCl, KCl and CaCl.

14. Cuttable wound care product (9) according to one of the preceding claims, wherein the pH of the aqueous salt solution stored in the swelling layer is in the range of 4.5 to 6.

9.

15. A cuttable wound care product (9) according to any one of the preceding claims, wherein the first layer (4) and the second layer (1) consist of an identical material or an identical material mixture.

16. A cuttable wound care product (9) according to any one of the preceding Claims, wherein the source layer (3) is not saturated with the salt solution stored therein.

Images